Schmid, A.; Arians, M.; Karrasch, T.; Pons-Kühnemann, J.; Schäffler, A.; Roderfeld, M.; Roeb, E.
Improvement of Type 2 Diabetes Mellitus and Attenuation of NAFLD Are Associated with the Success of Obesity Therapy. J. Clin. Med. 2022, 11, 1756.
https://doi.org/10.3390/jcm11071756
AMA Style
Schmid A, Arians M, Karrasch T, Pons-Kühnemann J, Schäffler A, Roderfeld M, Roeb E.
Improvement of Type 2 Diabetes Mellitus and Attenuation of NAFLD Are Associated with the Success of Obesity Therapy. Journal of Clinical Medicine. 2022; 11(7):1756.
https://doi.org/10.3390/jcm11071756
Chicago/Turabian Style
Schmid, Andreas, Miriam Arians, Thomas Karrasch, Jörn Pons-Kühnemann, Andreas Schäffler, Martin Roderfeld, and Elke Roeb.
2022. "Improvement of Type 2 Diabetes Mellitus and Attenuation of NAFLD Are Associated with the Success of Obesity Therapy" Journal of Clinical Medicine 11, no. 7: 1756.
https://doi.org/10.3390/jcm11071756
APA Style
Schmid, A., Arians, M., Karrasch, T., Pons-Kühnemann, J., Schäffler, A., Roderfeld, M., & Roeb, E.
(2022). Improvement of Type 2 Diabetes Mellitus and Attenuation of NAFLD Are Associated with the Success of Obesity Therapy. Journal of Clinical Medicine, 11(7), 1756.
https://doi.org/10.3390/jcm11071756
